• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

par

  1. A Slow Death to PAR & Endo

    We told you that Huntsville would prevail in the end. This is what happens when you bring on a leadership team that lies and has shady practices. The Ghost of Huntsville.

  2. Trump to Come to PAR Huntsville Site

    Donald Trump's administration has announced he will make a visit to the PAR Huntsville Site while in town to support Luther Strange for Senate. The sole purpose of the visit is to discuss the possibilities of keeping the site open to retain jobs in Alabama. There have been talks that Donald...
    • anonymous
    • Thread
    • endo par
    • Replies: 4
    • Forum: Endo

  3. PAR South Will Be Sold Off

    PAR South to be sold off. At least that's what it's looking like for everyone down in Alabama. Executive leadership does not understand how to handle high volume products. They fired a sales force to protect the ones at the PAR North facilities and volume is down 60% on every product. That...
    • anonymous
    • Thread
    • alabama drugs endo huntsville hydro opana packaging par par south will be sold off pharmaceuticals
    • Replies: 325
    • Forum: Endo
Top Bottom
Back